drugset / Trial / NCT05123651
Research on the Characteristics and Application of Lactobacillus Rhamnosus X253 as Oral Probiotics
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The aim of the study is to study the application of Lactobacillus rhamnosus X253 as oral probiotics by the way of a randomised, double blinded, parallel, placebo-controlled clinical trial, and to eto detect the changes in oral flora of volunteers, and judge the improvement effect of X253 lozenges on the human oral flora.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2021-02-14
- Completion
- 2021-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactobacillus rhamnosus X253 | Other / unclassified | 0.8 g | Oral |